AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
10.64
-0.08 (-0.75%)
At close: Jul 19, 2024, 4:00 PM
10.69
+0.05 (0.47%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 12.92, with a low estimate of 6.50 and a high estimate of 21. The average target predicts an increase of 21.43% from the current stock price of 10.64.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +22.18% | May 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +22.18% | Mar 4, 2024 |
| UBS | UBS | Strong Buy Maintains $9 → $13 | Strong Buy | Maintains | $9 → $13 | +22.18% | Feb 28, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +22.18% | Feb 28, 2024 |
| UBS | UBS | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | -15.41% | Jan 29, 2024 |
Financial Forecast
Revenue This Year
3.38B
from 3.20B
Increased by 5.62%
Revenue Next Year
3.57B
from 3.38B
Increased by 5.71%
EPS This Year
0.67
from -5.31
EPS Next Year
1.01
from 0.67
Increased by 49.85%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.5B | 3.7B | 4.1B |
| Avg | 3.4B | 3.6B | 3.4B |
| Low | 3.2B | 3.4B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 9.2% | 10.3% | 13.6% |
| Avg | 5.6% | 5.7% | -5.9% |
| Low | 1.1% | -0.1% | -56.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.92 | 1.33 | 1.38 | 1.66 | 1.99 |
| Avg | 0.67 | 1.01 | 1.04 | 1.61 | 1.94 |
| Low | 0.26 | 0.47 | 0.67 | 1.55 | 1.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 98.7% | 36.8% | 60.0% | 23.8% |
| Avg | - | 49.8% | 3.1% | 55.4% | 20.3% |
| Low | - | -29.9% | -33.7% | 49.3% | 15.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.